The Chonluten peptide you are familiar with, also known as T-34 peptide or EDG tripeptide, is a classic short peptide from the Russian Khavinson system that specifically targets the respiratory system organs. Its core amino acid sequence is Glu-Asp-Gly (glutamic acid-aspartic acid-glycine). It is a regulatory peptide specifically tailored for the human respiratory tract, precisely targeting the alveoli, bronchial epithelium, and respiratory mucosa of your lungs, unlike broad-spectrum repair peptides.
This peptide, relying on an advanced epigenetic regulatory mechanism, can directly act on the gene level of your lung cells, activating the lung's native repair genes, accelerating respiratory mucosal regeneration, and simultaneously powerfully inhibiting airway inflammation, blocking the progression of pulmonary fibrosis, and delaying lung cell aging and apoptosis. It fundamentally regulates respiratory function, achieving the triple core value of lung anti-inflammation, tissue repair, and anti-aging maintenance.
As you can clearly see, Chonluten peptide was specifically developed in the 1990s by the team of Professor Vladimir Khavinson, a leading authority on peptides, at the St. Petersburg Institute of Bioregulation and Gerontology in Russia. It is a core respiratory care product in Russia's classic organ-targeting peptide matrix.
In the early stages of development, the team screened and extracted natural active peptide fragments from the lung tissue of healthy mammals. To overcome the drawbacks of animal extracts, such as high impurities, poor stability, easy sensitization, and unstable activity, they ultimately purified a high-purity EDG tripeptide core sequence through artificial chemical synthesis technology. The initial research goal was to specifically address issues such as declining lung function, recurrent respiratory inflammation, post-viral lung damage, and pulmonary fibrosis, catering to the respiratory system care and post-operative rehabilitation needs of people of all ages.
1. Research Developments: For many years, Russia has continuously conducted cell experiments, animal experiments, and small-sample human clinical studies, repeatedly verifying the repair and conditioning effects of Chonluten on airway inflammation, lung tissue damage, and early pulmonary fibrosis. It is a mainstream research peptide in the fields of medical rehabilitation and lung anti-aging in Russia.
2. Market Popularity: From 2020 to 2026, driven by post-pandemic lung injury rehabilitation, increased national fitness upgrades, and the growing demand for anti-aging products among middle-aged and elderly individuals, this peptide has seen a continuous rise in popularity in the high-end health, sports rehabilitation, and anti-aging circles in Europe and America, becoming a recognized essential peptide for lung health.
3. Industry Positioning: Currently, the product is a research-grade dietary peptide and has not obtained FDA or EMA pharmaceutical approval. It is not a drug and is only used for scientific research and daily health maintenance. The mainstream market dosage forms are high-purity freeze-dried powder and oral capsules.
4. Combination Trends: The industry often uses it in combination with Vladonix thymosin and Epithalon anti-aging peptides to synergistically regulate respiratory immunity and delay systemic aging, making it a popular combination for high-end customized health maintenance.
You can refer to the following standardized commercial parameters to fully understand the product attributes:
- Core Sequence: Glu-Asp-Gly (EDG tripeptide)
- Product Aliases: T-34, AC-7 Lung Repair Peptide
- Molecular Weight: 275 Da (Ultra-small molecular structure, easily absorbed by the human body)
- Product Purity: Research grade ≥95%, high-end health care grade ≥98% (HPLC high-performance liquid chromatography detection)
- Mainstream Dosage Forms: Oral capsules, lyophilized injectable powder
- Absorption Characteristics: Can be absorbed through intestinal-specific peptide transporters, with oral bioavailability far exceeding traditional plant-based lung-nourishing health products
- Storage Stability: Dry powder can be stored for 2 years at room temperature when sealed; diluted powder can be stored for 30 days at 2–8℃; long-term storage is possible in a frozen environment.
You can flexibly choose an appropriate regimen based on your own respiratory condition and maintenance needs, safe and without side effects:
1. Oral Regimen (Daily First Choice, High Adaptability, High Compliance)
- Daily Lung Care: 10mg daily, taken on an empty stomach in the morning, for 10 days as one course of treatment. 2-3 courses per year. Effectively prevents natural decline in lung function.
- Respiratory Sub-health/Mild Discomfort: 10-15mg daily for 20 consecutive days as one course of treatment. Improves seasonal cough, shortness of breath, airway sensitivity, and excessive phlegm.
- Lung Injury/Post-illness/Surgery Rehabilitation: 20mg daily for 20 days as one course of treatment. Targeted repair of damaged alveoli and bronchial mucosa.
2. Subcutaneous Injection Protocol (Research-Efficient Version, Higher Absorption Rate)
- Standard Repair Dosage: 5-10mg daily for 10-20 days as one course of treatment.
- Enhanced Repair Dosage: 10mg daily for 20 consecutive days. Suitable for individuals with severe lung function decline and mild pulmonary fibrosis.
General Cycle Recommendation: A single continuous use should not exceed 20 days. Rest for 3-6 months after the course of treatment. Reuse is possible, but continuous use throughout the year is not recommended.
Using Chonluten peptides, you can achieve comprehensive respiratory tract care and damage repair. Its core functions are clearly defined:
- Airway Anti-inflammatory and Swelling Reduction: Effectively downregulates respiratory tract inflammatory factors, relieves bronchial congestion and edema, improves chronic cough, excessive phlegm, chest tightness, and shortness of breath, and stabilizes airway condition.
- Mucosal Regeneration and Repair: Activates lung repair genes, promotes the regeneration and repair of damaged alveolar and bronchial mucosa, and repairs respiratory tract damage caused by long-term smoking, air pollution, and viral infections.
- Anti-pulmonary fibrosis and Lung Protection: Inhibits the deposition of pulmonary fibrosis factors, blocks lung tissue hardening and aging, improves problems such as decreased vital capacity and shortness of breath after activity, and delays lung function decline.
- Regulates Respiratory Immunity: Enhances local respiratory tract immunity, reduces the probability of respiratory tract sensitivity and recurrent inflammation caused by seasonal changes, temperature differences, and environmental stimuli.
- Optimizes Cardiopulmonary Function: Improves blood oxygen utilization, improves shortness of breath and insufficient endurance after exercise, suitable for athletes to improve physical fitness, and suitable for middle-aged and elderly people to improve daily activity ability.
Compared to ordinary lung-nourishing health products, Chonluten peptides offer significant differentiated advantages:
- Precise Organ Targeting: Specifically targets your lungs and bronchial respiratory tract tissues, without interfering with other organs such as the heart, liver, spleen, and stomach. It has no off-target side effects, and its targeting ability far surpasses ordinary compound health products.
- Root Cause Conditioning and Repair: Unlike ordinary products that only relieve surface symptoms, it can repair lung cells at the gene level, blocking aging and fibrosis, addressing both the symptoms and the root cause.
- Extremely High Safety: Decades of clinical application verification in Russia have shown that it contains zero hormones, zero dependence, and zero toxin accumulation. It does not interfere with the endocrine system or the overall immune system, making it safe for compliant individuals to use.
- Excellent Absorption Efficiency: The ultra-small molecule short peptides are resistant to digestive enzyme breakdown, allowing for efficient absorption through oral administration. It achieves ideal health benefits without injections, making it easy to use.
- Comprehensive Application Scenarios: Covers daily anti-aging care, post-illness damage repair, sports performance enhancement, post-operative rehabilitation, and environmental damage management. It can be synergistically combined with various peptides and nutritional supplements.
You can objectively recognize the product's shortcomings and rationally plan your usage:
- Limited Clinical Evidence: Currently, only in vitro experiments, animal experiments, and small-sample human clinical data from Russia are available. There are no large-scale double-blind clinical trials in Europe and the United States, and no official pharmaceutical approval.
- Slow Onset of Action: As a cellular-level repair and conditioning product, it takes 2-3 weeks to perceive significant improvement. It cannot replace medication for emergency treatment of acute asthma, sudden respiratory distress, or other acute conditions.
- High Maintenance Costs: The high-purity artificial synthesis process is complex, resulting in higher production costs than affordable lung-nourishing teas, glucosamine, and other similar products.
- Insufficient Long-Term Human Data: There is currently no long-term human tracking data (over 5 years). Continuous, uninterrupted use is not recommended; intermittent maintenance according to a treatment course is necessary.
If you experience any of the following, you can use Chonluten peptides for targeted maintenance and repair:
- Chronic Respiratory Problems: Chronic bronchitis, seasonal airway sensitivity, recurring cough and phlegm, chest tightness and shortness of breath, airway hyperresponsiveness.
- Lung Function Decline in Middle-Aged and Elderly: Decreased lung elasticity and vital capacity after age 40, shortness of breath after daily activities, and susceptibility to recurrent respiratory infections.
- Post-Viral Lung Injury Rehabilitation: Sequelae such as chest tightness, shortness of breath, fatigue, pulmonary fibrosis shadows, and difficulty breathing following viral infections like COVID-19 and influenza.
- Environmental Lung Injury Maintenance: Lung toxin accumulation and mucosal damage caused by long-term smoking, exposure to secondhand smoke, dust, air pollution, and cooking fumes.
- Exercise Fitness Optimization: Shortness of breath during exercise, insufficient endurance, poor altitude adaptability, and a desire to improve blood oxygen saturation and strengthen cardiopulmonary endurance.
- Post-operative Lung Rehabilitation: After minimally invasive lung surgery, it helps reduce airway inflammation, repair damaged mucosa, and accelerate lung function recovery.
- Case 1: COPD Maintenance in Middle-aged and Elderly Individuals: A 58-year-old long-term smoker suffered from recurrent coughing, chest tightness, and shortness of breath after activity. After adhering to a standardized treatment course of 20mg daily for 20 days, cough and sputum production decreased by 60% after 3 weeks, shortness of breath was significantly relieved, and lung ventilation function was significantly improved.
- Case 2: Repair of Mild Pulmonary Fibrosis After Viral Infection: A 34-year-old woman experienced persistent chest tightness and fatigue after recovering from COVID-19, accompanied by mild pulmonary fibrosis. After using vitamin D for 20 days, her fatigue completely disappeared after 2 weeks, her shortness of breath largely subsided after 1 month, and a follow-up examination after 3 months showed a significant reduction in the size of the pulmonary fibrosis shadow.
- Case 3: Cardiopulmonary Improvement in Athletes: A 26-year-old long-distance runner experienced exercise-induced shortness of breath and discomfort during high-altitude training. Ten days prior to the race, a daily dose of 10mg of supplemental medication significantly improved exercise endurance, stabilized blood oxygen saturation, and greatly reduced post-exercise fatigue and shortness of breath.
1. Dietary Recommendations (To Enhance the Effects of Supplemental Care)
✅ Recommended Foods: High-quality protein (eggs, fish, soy products) to aid in the repair of lung mucosa; high-antioxidant foods (blueberries, broccoli, nuts, green tea) to reduce oxidative damage to the lungs; deep-sea fish oil and Omega-3 foods to enhance the respiratory tract's anti-inflammatory capabilities; adequate daily water intake to maintain respiratory mucosa moisture and accelerate metabolic repair.
❌ Strictly Limit/Avoid: Alcohol, high-sugar foods, fried and spicy foods, and pickled and irritating foods. These foods can worsen airway inflammation and irritate mucosal congestion and edema; also reduce the intake of strong tea and excessive coffee to avoid disrupting the body's repair and metabolic rhythm.
**Key Contraindications:** Smoking must be avoided during the treatment course. Excluding exposure to secondhand smoke and cooking fumes will directly negate the cell repair effects of the peptides and hinder the treatment progress.
2. **Precautions for Combined Use of Other Drugs:**
✅ Safe for Combined Use: Can be used in combination with Vitamin D, fish oil, NAC (acetylcysteine), mild cough and asthma relief supplements, and conventional bronchodilators. Synergistic effects are achieved without any conflicts.
⚠️ **Caution for Combined Use:** Anticoagulants (such as warfarin) and long-term glucocorticoids should be used at least 4 hours apart, with monitoring of body indicators to balance metabolism and anti-inflammatory mechanisms.
❌ **Not Recommended for Combined Use:** High-dose, potent immunosuppressants and strong anti-inflammatory drugs may interfere with Chonluten's immune regulation and tissue repair mechanisms, significantly reducing the therapeutic effect.
3. **Contraindications:** This product is contraindicated for pregnant women, breastfeeding women, individuals with peptide allergies, active tuberculosis, acute severe lung infections, and individuals with severe liver or kidney dysfunction. 4. Important Usage Reminders: Chonluten is a lung care and repair product, not an emergency medication. In case of acute asthma attacks, sudden difficulty breathing, severe lung infections, or other emergencies, seek medical treatment first. This product should not be used as a substitute for medication.
Hot Tags: High-purity peptide Chonluten 20mg/vial, China High-purity peptide Chonluten 20mg/vial manufacturers, suppliers, factory
